tert-Butyl 4-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate

Catalog No.: 
ACDHOI439
CAS No.: 
1056934-87-2
Molecular Formula: 
C12H16ClN3O2
Molecular Weight: 
269.73
tert-Butyl 4-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$167.00In stockIn stock
25g98%$594.00In stockIn stock
100g98%$1902.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate
IUPAC Nametert-butyl 4-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate
MDL No.MFCD08273922
Molecular FormulaC12H16ClN3O2
Molecular Weight269.73
SMILESO=C(N1CCC2=NC=NC(Cl)=C2C1)OC(C)(C)C
InChI KeyYSSUXXNMVJXCBS-UHFFFAOYSA-N
Synonymtert-butyl 4-chloro-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carboxylate | MFCD08273922 | tert-butyl 4-chloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxylate | tert-Butyl 4-chloro-7,8-dihydropyrido-[4,3-d]pyrimidine-6(5H)-carboxylate | tert-butyl 4-chlo
CAS No.1056934-87-2
PubChem CID56924365

Synthetic Route by SureRoute

1. ACDHOI439 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDHOI439 route product structure diagram
    ACDHOI4391056934-87-2In Stock
Inquiry

2. ACDHOI439 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDHOI439 route product structure diagram
    ACDHOI4391056934-87-2In Stock
Inquiry

3. ACDHOI439 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDHOI439 route product structure diagram
    ACDHOI4391056934-87-2In Stock
Inquiry

Comments (0)